392 related articles for article (PubMed ID: 22155606)
1. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.
Laycock-van Spyk S; Thomas N; Cooper DN; Upadhyaya M
Hum Genomics; 2011 Oct; 5(6):623-90. PubMed ID: 22155606
[TBL] [Abstract][Full Text] [Related]
2. Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas.
Thomas L; Spurlock G; Eudall C; Thomas NS; Mort M; Hamby SE; Chuzhanova N; Brems H; Legius E; Cooper DN; Upadhyaya M
Eur J Hum Genet; 2012 Apr; 20(4):411-9. PubMed ID: 22108604
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN
Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917
[TBL] [Abstract][Full Text] [Related]
4. The NF1 somatic mutational landscape in sporadic human cancers.
Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M
Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487
[TBL] [Abstract][Full Text] [Related]
5. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene.
Colman SD; Williams CA; Wallace MR
Nat Genet; 1995 Sep; 11(1):90-2. PubMed ID: 7550323
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous neurofibromas in the genomics era: current understanding and open questions.
Allaway RJ; Gosline SJC; La Rosa S; Knight P; Bakker A; Guinney J; Le LQ
Br J Cancer; 2018 Jun; 118(12):1539-1548. PubMed ID: 29695767
[TBL] [Abstract][Full Text] [Related]
7. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1.
Eisenbarth I; Beyer K; Krone W; Assum G
Am J Hum Genet; 2000 Feb; 66(2):393-401. PubMed ID: 10677298
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas.
Maertens O; Brems H; Vandesompele J; De Raedt T; Heyns I; Rosenbaum T; De Schepper S; De Paepe A; Mortier G; Janssens S; Speleman F; Legius E; Messiaen L
Hum Mutat; 2006 Oct; 27(10):1030-40. PubMed ID: 16941471
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
10. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.
Serra E; Ars E; Ravella A; Sánchez A; Puig S; Rosenbaum T; Estivill X; Lázaro C
Hum Genet; 2001 May; 108(5):416-29. PubMed ID: 11409870
[TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of neurofibromatosis-associated tumours.
Lin AL; Gutmann DH
Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
[TBL] [Abstract][Full Text] [Related]
12. Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types.
Spurlock G; Griffiths S; Uff J; Upadhyaya M
Fam Cancer; 2007; 6(4):463-71. PubMed ID: 17551851
[TBL] [Abstract][Full Text] [Related]
13. Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene.
Stewart W; Traynor JP; Cooke A; Griffiths S; Onen NF; Balsitis M; Shah AA; Upadhyaya M; Tobias ES
Fam Cancer; 2007; 6(1):147-52. PubMed ID: 16944271
[TBL] [Abstract][Full Text] [Related]
14. A search for evidence of somatic mutations in the NF1 gene.
John AM; Ruggieri M; Ferner R; Upadhyaya M
J Med Genet; 2000 Jan; 37(1):44-9. PubMed ID: 10633134
[TBL] [Abstract][Full Text] [Related]
15. Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours.
Bottillo I; Ahlquist T; Brekke H; Danielsen SA; van den Berg E; Mertens F; Lothe RA; Dallapiccola B
J Pathol; 2009 Apr; 217(5):693-701. PubMed ID: 19142971
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and NF1 gene mutation analysis of three successive generations in three different Indian families with neurofibromatosis type 1 and peripheral nerve sheath tumours.
Prasad BCM; Chandra VVR; Sudarsan A; Kumar PS; Sarma PVGK
J Clin Neurosci; 2018 Jul; 53():62-68. PubMed ID: 29680440
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
Legius E; Brems H
Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
[TBL] [Abstract][Full Text] [Related]
18. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.
Serra E; Puig S; Otero D; Gaona A; Kruyer H; Ars E; Estivill X; Lázaro C
Am J Hum Genet; 1997 Sep; 61(3):512-9. PubMed ID: 9326316
[TBL] [Abstract][Full Text] [Related]
19. The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs).
Upadhyaya M; Spurlock G; Majounie E; Griffiths S; Forrester N; Baser M; Huson SM; Gareth Evans D; Ferner R
Hum Mutat; 2006 Jul; 27(7):716. PubMed ID: 16786508
[TBL] [Abstract][Full Text] [Related]
20. Germline Neurofibromin 1 mutation enhances the anti-tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity.
Wang W; Li X; Qin X; Miao Y; Zhang Y; Li S; Yao R; Yang Y; Yu L; Zhu H; Song L; Mao S; Wang X; Chen J; Feng H; Li Y
Br J Haematol; 2023 Jul; 202(2):328-343. PubMed ID: 37144690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]